British Journal of Haematology logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 156, Number 4, 1 February 2012

< previous issue | all issues | next issue >

Unusual colours of plasma
pp. 419-419(1)
Authors: Guignard, Julie; Tissot, Jean-Daniel; Canellini, Giorgia

Expression of multiple cytokines and CCR4 in primary testicular diffuse large B-cell lymphoma, not otherwise specified, involving the skin
pp. 420-420(1)
Authors: Nakayama-Ichiyama, Shoko; Iwaki, Kazuki; Yokote, Taiji; Tsuji, Motomu; Hirata, Yuji; Hanafusa, Toshiaki

Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system
pp. 421-432(12)
Authors: Baraniskin, Alexander; Deckert, Martina; Schulte-Altedorneburg, Gernot; Schlegel, Uwe; Schroers, Roland

Biomarkers in sickle cell disease
pp. 433-445(13)
Authors: Rees, David C.; Gibson, John S.

Guidelines on the investigation and management of follicular lymphoma
pp. 446-467(22)
Authors: McNamara, Christopher; Davies, John; Dyer, Martin; Hoskin, Peter; Illidge, Tim; Lyttelton, Matthew; Marcus, Robert; Montoto, Silvia; Ramsay, Alan; Wong, Wai Lup; Ardeshna, Kint

Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with <i>FLT3</i> mutation status - consequences and potentials for pharmacological intervention
pp. 468-480(13)
Authors: Reikvam, Håkon; Hatfield, Kimberley J.; Ersvær, Elisabeth; Hovland, Randi; Skavland, Jørn; Gjertsen, Bjørn T.; Petersen, Kjell; Bruserud, Øystein

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients
pp. 481-489(9)
Authors: Cortelezzi, Agostino; Gritti, Giuseppe; Laurenti, Luca; Cuneo, Antonio; Ciolli, Stefania; Di Renzo, Nicola; Musto, Pellegrino; Mauro, Francesca R.; Cascavilla, Nicola; Falchi, Lorenzo; Zallio, Francesco; Callea, Vincenzo; Maura, Francesco; Martinelli, Sara; Piciocchi, Alfonso; Reda, Gianluigi; Foà, Robin; on behalf of the GIMEMA Chronic Lymphoproliferative Disorders Working Partycr18,

Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma
pp. 490-498(9)
Authors: Barth, Matthew J.; Hernandez-Ilizaliturri, Francisco J.; Mavis, Cory; Tsai, Ping-Chiao; Gibbs, John F.; Deeb, George; Czuczman, Myron S.

Defining the prognosis of early stage chronic lymphocytic leukaemia patients
pp. 499-507(9)
Authors: Pepper, Chris; Majid, Aneela; Lin, Thet Thet; Hewamana, Saman; Pratt, Guy; Walewska, Renata; Gesk, Stefan; Siebert, Reiner; Wagner, Simon; Kennedy, Ben; Miall, Fiona; Davis, Zadie A.; Tracy, Ian; Gardiner, Anne C.; Brennan, Paul; Hills, Robert K.; Dyer, Martin J. S.; Oscier, David; Fegan, Chris

Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin
pp. 508-515(8)
Authors: Winkler, Jeannine; Kroiss, Sabine; Rand, Margaret L.; Azzouzi, Imane; Annie Bang, K. W.; Speer, Oliver; Schmugge, Markus

Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure
pp. 516-522(7)
Authors: Mohamedbhai, Sajir G.; Edwards, Noha; Morris, Emma C.; Mackinnon, Stephen; Thomson, Kirsty J.; Peggs, Karl S.

Regulation of fas/fas ligand-mediated apoptosis by nuclear factor of activated T cells in megakaryocytes
pp. 523-534(12)
Authors: Arabanian, Laleh S.; Kujawski, Satu; Habermann, Ivonne; Ehninger, Gerhard; Kiani, Alexander

Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness
pp. 535-544(10)
Authors: Cain, David M.; Vang, Derek; Simone, Donald A.; Hebbel, Robert P.; Gupta, Kalpna

Red cells exchanges in sickle cells disease lead to a selective reduction of erythrocytes-derived blood microparticles
pp. 545-547(3)
Authors: Mahfoudhi, Emna; Lecluse, Yann; Driss, Françoise; Abbes, Salem; Flaujac, Claire; Garçon, Loïc

The eukaryotic Initiating Factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemia
pp. 547-550(4)
Authors: Green, Alexa S.; Grabar, Sophie; Tulliez, Micheline; Park, Sophie; Al-Nawakil, Chadi; Chapuis, Nicolas; Jacque, Nathalie; Willems, Lise; Azar, Nabih; Ifrah, Norbert; Dreyfus, François; Lacombe, Catherine; Mayeux, Patrick; Bouscary, Didier; Tamburini, Jerome

Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma
pp. 552-555(4)
Authors: Grey-Davies, Elisabeth; Bosworth, Jennifer L.; Boyd, Kevin D.; Ebdon, Caroline; Saso, Radovan; Chitnavis, Dipti; Mercieca, Jane E.; Morgan, Gareth J.; Davies, Faith E.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page